Note of Thanks for Data Donation for an Important Publication on the Treatment of Spasticity in ALS

The month of September 2019 saw the publication of data drawn from the APST network on the use of nabiximols in the treatment of spasticity in Amyotrophic Lateral Sclerosis (ALS). Please follow

Exercise Bikes Test: What Benefits Can Exercise Bikes Bring About in Amyotrophic Lateral Sclerosis?

People with Amyotrophic Lateral Sclerosis (ALS) suffer from slowly progressive muscle weakness (paresis), muscle wasting (atrophy) and stiffness (spasticity) of the arms and legs. Medical

4th Status Meeting for the Register Study on the Care of Patients with ALS

At this year’s German Neurological Association Annual Congress Ambulanzpartner hosts the “4th Status Meeting for the Register Study on the Provision of Assistive Technology Devices and

New Assistive Technology and Devices Classification Software Is Going Live

Since 2011, more than 76,000 provisions of assistive technology and devices have been coordinated and documented via the APST Internet platform. Approximately 9,000 patients as well as

Study to Capture the Treatment with Nusinersen

Nusinersen (Spinraza®) is an approved drug for the treatment of 5q-associated Spinal Muscular Atrophy (SMA). Infants and children treated with Nusinersen may experience cessation of disease